SIMILAR PATTERNS OF AMINO ACIDS FOR 5L7I_A_VISA1202_1
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1nyq | THREONYL-TRNASYNTHETASE 1 (Staphylococcusaureus) |
PF00587(tRNA-synt_2b)PF02824(TGS)PF03129(HGTP_anticodon)PF07973(tRNA_SAD) | 5 | TYR A 468PHE A 493ASN A 335LEU A 383MET A 363 | NoneNoneNoneTSB A1002 (-4.6A)TSB A1002 ( 4.1A) | 1.40A | 5l7iA-1nyqA:0.0 | 5l7iA-1nyqA:21.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1s7j | PHENAZINEBIOSYNTHESIS PROTEINPHZF FAMILY (Enterococcusfaecalis) |
PF02567(PhzC-PhzF) | 5 | ASN A 19ASP A 200ARG A 144ASN A 209LEU A 210 | None | 1.36A | 5l7iA-1s7jA:0.0 | 5l7iA-1s7jA:17.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2b1p | MITOGEN-ACTIVATEDPROTEIN KINASE 10 (Homo sapiens) |
PF00069(Pkinase) | 5 | TRP A 272ASP A 343ARG A 347GLU A 233LEU A 236 | NoneSO4 A 503 (-4.7A)NoneNoneNone | 1.46A | 5l7iA-2b1pA:2.1 | 5l7iA-2b1pA:20.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2fvm | DIHYDROPYRIMIDINASE (Lachanceakluyveri) |
PF01979(Amidohydro_1) | 5 | ASP A 307SER A 310ARG A 411GLU A 487LEU A 468 | None | 1.36A | 5l7iA-2fvmA:0.3 | 5l7iA-2fvmA:20.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3sfz | APOPTOTIC PEPTIDASEACTIVATING FACTOR 1 (Mus musculus) |
PF00400(WD40)PF00931(NB-ARC)PF12894(ANAPC4_WD40) | 5 | ASN A1238ASP A1237TYR A1243ASN A 551LEU A 550 | NoneNoneNoneGBL A1254 (-3.4A)GBL A1254 ( 4.2A) | 1.48A | 5l7iA-3sfzA:2.9 | 5l7iA-3sfzA:20.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4dun | PUTATIVE PHENAZINEBIOSYNTHESISPHZC/PHZF PROTEIN (Clostridioidesdifficile) |
PF02567(PhzC-PhzF) | 5 | ASN A 17ASP A 197ARG A 142ASN A 206LEU A 207 | BTB A 302 ( 4.6A)BTB A 302 (-2.8A)BTB A 302 ( 4.4A)NoneNone | 1.25A | 5l7iA-4dunA:undetectable | 5l7iA-4dunA:18.34 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4n4w | CYTOCHROMEB(562),SMOOTHENEDHOMOLOG (Homo sapiens;Shigellaflexneri) |
PF01534(Frizzled)PF07361(Cytochrom_B562) | 11 | ASN A 219TRP A 281ASP A 384SER A 387TYR A 394ARG A 400GLN A 477PHE A 484GLU A 518ASN A 521LEU A 522 | NoneNoneSNT A 605 ( 4.7A)SNT A 605 (-4.6A)NoneNoneNoneNoneSNT A 605 (-4.0A)SNT A 605 (-3.6A)SNT A 605 ( 4.4A) | 0.65A | 5l7iA-4n4wA:45.6 | 5l7iA-4n4wA:61.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4n4w | CYTOCHROMEB(562),SMOOTHENEDHOMOLOG (Homo sapiens;Shigellaflexneri) |
PF01534(Frizzled)PF07361(Cytochrom_B562) | 8 | ASN A 219TRP A 281ASP A 384SER A 387TYR A 394GLN A 477LEU A 522MET A 525 | NoneNoneSNT A 605 ( 4.7A)SNT A 605 (-4.6A)NoneNoneSNT A 605 ( 4.4A)SNT A 605 (-4.6A) | 0.73A | 5l7iA-4n4wA:45.6 | 5l7iA-4n4wA:61.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4o9r | SMOOTHENEDHOMOLOG/SOLUBLECYTOCHROME B562CHIMERIC PROTEIN (Escherichiacoli;Homo sapiens) |
PF01534(Frizzled)PF07361(Cytochrom_B562) | 6 | ASN A 219TRP A 281ASP A 384SER A 387LEU A 522MET A 525 | CY8 A1201 (-3.3A)NoneCY8 A1201 (-3.2A)NoneNoneNone | 1.04A | 5l7iA-4o9rA:44.5 | 5l7iA-4o9rA:74.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4o9r | SMOOTHENEDHOMOLOG/SOLUBLECYTOCHROME B562CHIMERIC PROTEIN (Escherichiacoli;Homo sapiens) |
PF01534(Frizzled)PF07361(Cytochrom_B562) | 10 | ASN A 219TRP A 281ASP A 384SER A 387TYR A 394ARG A 400GLN A 477GLU A 518ASN A 521LEU A 522 | CY8 A1201 (-3.3A)NoneCY8 A1201 (-3.2A)NoneCY8 A1201 (-4.3A)CY8 A1201 (-3.9A)CY8 A1201 (-3.7A)CY8 A1201 (-3.3A)NoneNone | 0.85A | 5l7iA-4o9rA:44.5 | 5l7iA-4o9rA:74.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4o9r | SMOOTHENEDHOMOLOG/SOLUBLECYTOCHROME B562CHIMERIC PROTEIN (Escherichiacoli;Homo sapiens) |
PF01534(Frizzled)PF07361(Cytochrom_B562) | 5 | TYR A 394ARG A 400GLN A 477PHE A 484LEU A 522 | CY8 A1201 (-4.3A)CY8 A1201 (-3.9A)CY8 A1201 (-3.7A)CY8 A1201 (-3.9A)None | 0.89A | 5l7iA-4o9rA:44.5 | 5l7iA-4o9rA:74.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5l7d | SMOOTHENEDHOMOLOG,SOLUBLECYTOCHROMEB562,SMOOTHENEDHOMOLOG (Escherichiacoli;Homo sapiens) |
PF01392(Fz)PF01534(Frizzled)PF07361(Cytochrom_B562) | 10 | ASN A 219TRP A 281ASP A 384SER A 387TYR A 394ARG A 400GLN A 477GLU A 518ASN A 521LEU A 522 | None | 0.68A | 5l7iA-5l7dA:45.1 | 5l7iA-5l7dA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5l7d | SMOOTHENEDHOMOLOG,SOLUBLECYTOCHROMEB562,SMOOTHENEDHOMOLOG (Escherichiacoli;Homo sapiens) |
PF01392(Fz)PF01534(Frizzled)PF07361(Cytochrom_B562) | 8 | ASN A 219TRP A 281ASP A 384SER A 387TYR A 394GLN A 477LEU A 522MET A 525 | None | 0.86A | 5l7iA-5l7dA:45.1 | 5l7iA-5l7dA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5l7d | SMOOTHENEDHOMOLOG,SOLUBLECYTOCHROMEB562,SMOOTHENEDHOMOLOG (Escherichiacoli;Homo sapiens) |
PF01392(Fz)PF01534(Frizzled)PF07361(Cytochrom_B562) | 5 | GLN A 477PHE A 484GLU A 518ASN A 521LEU A 522 | None | 0.78A | 5l7iA-5l7dA:45.1 | 5l7iA-5l7dA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5v57 | SMOOTHENEDHOMOLOG,FLAVODOXIN,SMOOTHENED HOMOLOG (Desulfovibriovulgaris;Homo sapiens) |
PF00258(Flavodoxin_1)PF01392(Fz)PF01534(Frizzled) | 11 | ASN A 219TRP A 281ASP A 384SER A 387TYR A 394ARG A 400GLN A 477PHE A 484GLU A 518ASN A 521LEU A 522 | 836 A1201 (-3.1A)None836 A1201 (-3.1A)836 A1201 (-4.5A)836 A1201 (-4.6A)836 A1201 (-3.0A)836 A1201 (-3.6A)836 A1201 (-3.9A)836 A1201 (-3.5A)836 A1201 (-3.4A)836 A1201 (-4.6A) | 0.56A | 5l7iA-5v57A:45.8 | 5l7iA-5v57A:79.05 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5v57 | SMOOTHENEDHOMOLOG,FLAVODOXIN,SMOOTHENED HOMOLOG (Desulfovibriovulgaris;Homo sapiens) |
PF00258(Flavodoxin_1)PF01392(Fz)PF01534(Frizzled) | 5 | TRP A 281ASP A 384SER A 387LEU A 522MET A 525 | None836 A1201 (-3.1A)836 A1201 (-4.5A)836 A1201 (-4.6A)None | 1.10A | 5l7iA-5v57A:45.8 | 5l7iA-5v57A:79.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6d35 | SMOOTHENED,SOLUBLECYTOCHROMEB562,SMOOTHENED (Escherichiacoli;Xenopus laevis) |
no annotation | 8 | ASN A 192ASP A 357SER A 360TYR A 367GLN A 450GLU A 491ASN A 494MET A 498 | None | 0.98A | 5l7iA-6d35A:39.8 | 5l7iA-6d35A:12.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6d35 | SMOOTHENED,SOLUBLECYTOCHROMEB562,SMOOTHENED (Escherichiacoli;Xenopus laevis) |
no annotation | 8 | ASN A 192SER A 360TYR A 367GLN A 450GLU A 491ASN A 494LEU A 495MET A 498 | None | 0.88A | 5l7iA-6d35A:39.8 | 5l7iA-6d35A:12.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6d35 | SMOOTHENED,SOLUBLECYTOCHROMEB562,SMOOTHENED (Escherichiacoli;Xenopus laevis) |
no annotation | 8 | ASN A 192TRP A 254ASP A 357SER A 360TYR A 367ARG A 373GLU A 491ASN A 494 | None | 0.92A | 5l7iA-6d35A:39.8 | 5l7iA-6d35A:12.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6d35 | SMOOTHENED,SOLUBLECYTOCHROMEB562,SMOOTHENED (Escherichiacoli;Xenopus laevis) |
no annotation | 8 | ASN A 192TRP A 254ASP A 357SER A 360TYR A 367GLU A 491ASN A 494MET A 498 | None | 0.89A | 5l7iA-6d35A:39.8 | 5l7iA-6d35A:12.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6d35 | SMOOTHENED,SOLUBLECYTOCHROMEB562,SMOOTHENED (Escherichiacoli;Xenopus laevis) |
no annotation | 8 | ASN A 192TRP A 254SER A 360TYR A 367ARG A 373GLU A 491ASN A 494LEU A 495 | None | 0.88A | 5l7iA-6d35A:39.8 | 5l7iA-6d35A:12.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6d35 | SMOOTHENED,SOLUBLECYTOCHROMEB562,SMOOTHENED (Escherichiacoli;Xenopus laevis) |
no annotation | 8 | ASN A 192TRP A 254SER A 360TYR A 367GLU A 491ASN A 494LEU A 495MET A 498 | None | 0.81A | 5l7iA-6d35A:39.8 | 5l7iA-6d35A:12.29 |